Advertisement

The Anti-Inflammatory and Antioxidant Effects of Propofol and Sevoflurane in Children With Cyanotic Congenital Heart Disease

Published:September 30, 2022DOI:https://doi.org/10.1053/j.jvca.2022.09.094

      Objective

      The authors aimed to compare the anti-inflammatory and antioxidant effects of propofol and sevoflurane in children with cyanotic congenital heart disease (CCHD) undergoing cardiac surgery with cardiopulmonary bypass.

      Design

      Prospective, randomized, double-blind study.

      Setting

      Single center, university hospital.

      Participants

      Children ages 1-10 years with CCHD undergoing elective cardiac surgery with cardiopulmonary bypass.

      Interventions

      Children were randomized to receive general anesthesia with either sevoflurane (group S) or propofol (group P). Systemic inflammatory response syndrome (SIRS) occurrence was assessed at the end of the surgery and at the sixth, 12th, and 24th postoperative hours. Blood samples were obtained at 4 times: after anesthesia induction (T0), after release of the aortic cross-clamp (T1), at the end of the surgery (T2), and at the postoperative 24th hour (T3). The serum levels of interleukin 6 and tumor necrosis factor alpha, and the total antioxidant status (TAS) and total oxidant status, were analyzed.

      Results

      SIRS was more common in group S than in group P at all times (p = 0.020, p = 0.036, p = 0.004, p = 0.008). There were no significant differences between the groups in the mean tumor necrosis factor alpha and interleukin 6 levels at any time. The TAS level at T2 was higher in group P than group S (p = 0.036). The serum TAS level increased at T2 compared with T0 in group P, but it decreased in group S (p = 0.041).

      Conclusion

      The results showed that propofol provided a greater antioxidant effect and reduced SIRS postoperatively more than sevoflurane in children with CCHD undergoing cardiac surgery.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Schmid E
        • Krajewski S
        • Bachmann D
        • et al.
        The volatile anesthetic sevoflurane inhibits activation of neutrophil granulocytes during simulated extracorporeal circulation.
        Int J Immunopharmacol. 2012; 14: 202-208
        • Fudulu D
        • Angelini G.
        Oxidative stress after surgery on the immature heart.
        Oxid Med Cell Longev. 2016; 20161971452
        • Durandy Y.
        Minimizing systemic inflammation during cardiopulmonary bypass in the pediatric population.
        Artif Organs. 2014; 38: 11-18
        • Sharma R
        • Bolger AP
        • Li W
        • et al.
        Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease.
        Am J Cardiol. 2003; 92: 188-193
        • Nassef YE
        • Hamed MA
        • Aly HF.
        Inflammatory cytokines, apoptotic, tissue injury and remodeling biomarkers in children with congenital heart disease.
        Indian J Clin Biochem. 2014; 29: 145-149
        • El-Azab SR
        • Rosseel PMJ
        • DeLange JJ
        • et al.
        Effect of sevoflurane on the ex vivo secretion of TNF-α during and after coronary artery bypass surgery.
        Eur J Anaesth. 2003; 20: 380-384
        • Samir A
        • Gandreti N
        • Madhere M
        • et al.
        Anti-inflammatory effects of propofol during cardiopulmonary bypass: A pilot study.
        Ann Card Anaesth. 2015; 18: 495-501
        • Dumaresq DMH
        • de Vasconcelos RC
        • Guimarães SB
        • et al.
        Metabolic and oxidative effects of sevoflurane and propofol in children undergoing surgery for congenital heart disease.
        Acta Cir Bras. 2011; 26: 66-71
        • Bettex DA
        • Wanner PM
        • Bosshart M
        • et al.
        Role of sevoflurane in organ protection during cardiac surgery in children: A randomized controlled trial.
        Interact Cardiovasc Thorac Surg. 2015; 20: 157-165
        • Gaies MG
        • Gurney JG
        • Yen AH
        • et al.
        Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass.
        Pediatr Crit Care Med. 2010; 11: 234-238
        • Jenkins KJ
        • Gauvreau K
        • Newburger JW
        • et al.
        Consensus-based method for risk adjustment for surgery for congenital heart disease.
        J Thorac Cardiovasc Surg. 2002; 123: 110-118
        • Goldstein B
        • Giroir B
        • Randolph A
        • et al.
        International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics.
        Pediatr Crit Care Med. 2005; 6: 2-8
        • Geng YJ
        • Wu QH
        • Zhang RQ.
        Effect of propofol, sevoflurane, and isoflurane on postoperative cognitive dysfunction following laparoscopic cholecystectomy in elderly patients: A randomized controlled trial.
        J Clin Anesth. 2017; 38: 165-171
        • Squiccimarro E
        • Labriola C
        • Malvind PG
        • et al.
        Prevalence and clinical impact of systemic inflammatory reaction after cardiac surgery.
        J Cardiothorac Vasc Anesth. 2019; 33: 1682-1690
        • Cho EJ
        • Yoon JH
        • Hong SJ
        • et al.
        The effects of sevoflurane on systemic and pulmonary inflammatory responses after cardiopulmonary bypass.
        J Cardiothorac Vasc Anesth. 2009; 23: 639-645
        • Yang XL
        • Wang D
        • Zhang GY
        • et al.
        Comparison of the myocardial protective effect of sevoflurane versus propofol in patients undergoing heart valve replacement surgery with cardiopulmonary bypass.
        BMC Anesthesiol. 2017; 17: 37
        • Allen BS
        • Rahman S
        • Ilbawi MN
        • et al.
        Detrimental effects of cardiopulmonary bypass in cyanotic infants: Preventing the reoxygenation injury.
        Ann Thorac Surg. 1997; 64 (discussion 1387-8): 1381-1387
        • Ballester M
        • Llorens J
        • Garcia-de-la-Asuncion G
        • et al.
        Myocardial oxidative stress protection by sevoflurane vs. propofol: A randomised controlled study in patients undergoing off-pump coronary artery bypass graft surgery.
        Eur J Anaesthesiol. 2011; 28: 874-881
        • Hanouz J-L
        • Zhu L
        • Lemoine S
        • et al.
        Reactive oxygen species mediate sevoflurane- and desflurane-induced preconditioning in isolated human right atria in vitro.
        Anesth Analg. 2007; 105: 1534-1539
        • Baker JE
        • Holman P
        • Gross GJ.
        Preconditioning in immature rabbit hearts role of KATP channels.
        Circulation. 1999; 99: 1249-1254
        • Jakobsen CJ
        • Berg H
        • Hindsholm KB
        • et al.
        The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgical procedures.
        J Cardiothorac Vasc Anesth. 2007; 21: 664-671
        • Yu QB
        • Li HM
        • Li LL
        • et al.
        Sevoflurane downregulates interleukin-6 and interleukin-8 levels in patients after cardiopulmonary bypass surgery: A meta-analysis.
        Genet Mol Res. 2015; 14: 19016-19027
        • Suleiman MS
        • Zacharowski K
        • Angelini GD.
        Inflammatory response and cardioprotection during open-heart surgery: The importance of anaesthetics.
        Br J Pharmacol. 2008; 153: 21-33